Common variations of CD2AP have been associated with kidney problems and late-onset Alzheimer’s diseases [20], [21], in which CD2AP was found to be involved in the abnormal cytoskeletal structural regulation and cell–cell contacts [22], [23]. Here, CD2AP is linked to Alzheimer disease.